özgür yağan

özgür yağan

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Brazilian Journal of Anesthesiology (English Edition)
Verified
Journal Article
Open access
ÖYözgür yağan
özgür yağan
NTNilay Taş
Nilay Taş
TMTuğçe Mutlu
Tuğçe Mutlu
VHVolkan Hancı
Volkan Hancı
The aim of our study is to compare the effects of sugammadex and neostigmine, used for neuromuscular blockage antagonism, on postoperative nausea and vomiting (PONV). Our study was completed with 98 ASA I-II risk patients undergoing endotracheal intubation under general anesthesia. At the end of the surgery patients were randomly divided into two groups given 2 mg kg−1 sugammadex (Group S) or 50 μg kg−1 neostigmine plus 0.2 mg kg−1 atropine (Group N). Monitoring and recording times were set as 1 hour postoperative and from 1–6, 6–12, and 12–24 hours. The anti-emetic amounts administered were recorded. In the first hour postoperative 13 patients in Group N (27%) and 4 in Group S (8%) were observed to have nausea and/or vomiting and the difference was statistically significant (p = 0.0016). During the 24 hours of monitoring there was no significant difference in the incidence and severity of PONV (p > 0.05), however the number of patients given ondansetron for PONV treatment in Group N was statistically significantly higher than the number in Group S (16 in Group N, 6 in Group S, p < 0.011). At the end of our study comparing neostigmine with sugammadex for neuromuscular blockage antagonism, we found use of sugammadex had lower incidence of PONV in the postoperative 1st hour and less anti-emetic use in 24 hours of monitoring. O objetivo de nosso estudo foi comparar os efeitos de sugamadex e neostigmina, usados para o antagonismo do bloqueio neuromuscular em náusea e vômito no pós-operatório (NVPO). O estudo foi concluído com 98 pacientes de risco ASA I-II, submetidos à intubação traqueal sob anestesia geral. Ao final da cirurgia, os pacientes foram aleatoriamente divididos em dois grupos que receberam 2 mg kg−1 de sugamadex (Grupo A) ou 50 μg kg−1 de neostigmina mais 0,2 mg kg−1 de atropina (Grupo N). Os tempos de monitoração e registro foram definidos como 1 hora de pós-operatório e de 1-6, 6-12 e 12-24 horas. As quantidades administradas de antieméticos foram registradas. Na primeira hora de pós-operatório, 13 pacientes do Grupo N (27%) e 4 do Grupo S (8%) apresentaram náusea e/ou vômito e a diferença foi estatisticamente significativa (p = 0,0016). Não houve diferença significativa na incidência e gravidade de NVPO (p > 0,05) durante as 24 horas de monitoração, porém o número de pacientes que recebeu ondansetron para o tratamento de NVPO no Grupo N foi estatística e significativamente maior que o número de pacientes no Grupo S (16 e 6, respectivamente, p < 0,011). Ao final do estudo quando comparamos neostigmina com sugamadex para o antagonismo do bloqueio neuromuscular descobrimos que sugamadex apresentou menor incidência de NVPO na primeira hora de pós-operatório e consumo menor de antiemético em 24 horas de monitoração.

18 March 2015 in Turkish Journal of Anaesthesiology and Reanimation
Verified
Journal Article
Closed access
ÖYözgür yağan
özgür yağan
RKRefika Hande Karakahya
Refika Hande Karakahya
NTNilay Tas
Nilay Tas
AKAhmet Kucuk
Ahmet Kucuk
The aim of this study is to compare the sedative properties and haemodynamic and respiratory effects of dexmedetomidine and a ketamine-propofol combination (ketofol), which are expected to have minimal effects on spontaneous breathing. Sixty patients were enrolled in this prospective randomised study. Patients were divided into 2 groups according to the administration of dexmedetomidine (Group D) and ketofol (Group K). Target sedation level was determined as a Ramsay Sedation Score of 3. In Group D, 0.5 mcg kg(-1) dexmedetomidine was administered via intravenous route in 10 minutes versus 0.125 mL kg(-1) of a solution containing 200 mg propofol and 100 mg ketamine in Group K. Haemodynamic and respiratory effects, postoperative awakening time, analgesic properties and satisfaction levels of the patients and surgeon were assessed. There was a statistically significant decrease in mean arterial pressures following drug administration compared to initial measurements in both groups. However, there was a statistically significant decrease in heart rate only in Group D. There was no significant difference between the two groups regarding respiratory rate and protection of spontaneous respiration. Although the time for Aldrete score to be 9 was 16.1 minutes for Group K, it was 24.9 minutes for Group D, and this difference was statistically significant (p<0.01). There was no significant difference between the two groups regarding adverse effects, pain scores and satisfaction levels of the patients and surgeon. Compared to dexmedetomidine, at similar sedation levels, sedation provided by ketofol enables satisfactory analgesia. Moreover, ketofol has a more rapid onset of action and a shorter recovery period from anaesthesia without causing significant haemodynamic or respiratory adverse effects.

26 November 2015 in Journal of Cardiovascular and Thoracic Research
Verified
Journal Article
Open access
ÖYözgür yağan
özgür yağan
NTNilay Taş
Nilay Taş
AKAhmet Küçük
Ahmet Küçük
VHVolkan Hanci
Volkan Hanci
BYBülent Serhan Yurtlu
Bülent Serhan Yurtlu
Etomidate-propofol combination may be a valuable alternative when extremes of hypotensive and hypertensive responses due to propofol and etomidate are best to be avoided.

1 September 2016 in Revista Brasileira de Anestesiologia
Verified
Journal Article
Open access
ÖYözgür yağan
özgür yağan
KÖKadir Özyilmaz
Kadir Özyilmaz
AÖAhmet Özmaden
Ahmet Özmaden
ÖSÖzgür Sayin
Özgür Sayin
VHVolkan Hanci
Volkan Hanci
ResumoA síndrome da pessoa rígida (SPR), caracterizada pela rigidez dos músculos do tronco e das extremidades e por episódios de espasmos dolorosos, é uma doença neurológica autoimune rara. Apresentamos o ocaso de intubação endotraqueal bem‐sucedida e aplicação de AVT sem relaxantes musculares em um paciente com SPR.Paciente do sexo masculino, 46 anos, estado físico ASA‐II, submetido à cirurgia devido à fratura por compressão da coluna lombar. Após a indução da anestesia com lidocaína, propofol e remifentanil, a intubação traqueal foi concluída com facilidade, sem bloqueio neuromuscular. A anestesia foi mantida com propofol, remifentanil e mistura de ar/O2. Após o período intraoperatório, que transcorreu sem intercorrências, o paciente foi extubado e, sete dias depois, recebeu alta, deambulando com ajuda.Embora o mecanismo não esteja claro, bloqueadores neuromusculares e anestésicos voláteis podem causar hipotonia prolongada em pacientes com SPR. Acreditamos que a técnica de AVT, uma prática de anestesia geral que não requer bloqueio neuromuscular, é adequada para esses pacientes.AbstractStiff Person Syndrome (SPS), typified by rigidity in muscles of the torso and extremities and painful episodic spasms, is a rare autoimmune‐based neurological disease. Here we present the successful endotracheal intubation and application of TIVA without muscle relaxants on an SPS patient.A 46 years old male patient was operated with ASA‐II physical status because of lumber vertebral compression fracture. After induction of anesthesia using lidocaine, propofol and remifentanil tracheal intubation was completed easily without neuromuscular blockage. Anesthesia was maintained with propofol, remifentanil and O2/air mixture. After a problem‐free intraoperative period the patient was extubated and seven days later was discharged walking with aid.Though the mechanism is not clear neuromuscular blockers and volatile anesthetics may cause prolonged hypotonia in patients with SPS. We think the TIVA technique, a general anesthetic practice which does not require neuromuscular blockage, is suitable for these patients

30 January 2015 in Turkish Journal of Anaesthesiology and Reanimation
Verified
Journal Article
Closed access
ÖYözgür yağan
özgür yağan
KOKadir Ozyilmaz
Kadir Ozyilmaz
NTNilay Tas
Nilay Tas
VHVolkan Hanci
Volkan Hanci
The aim of this study is to compare general anaesthesia (GA) versus regional anaesthesia (RA) for endovascular aneurysm repair (EVAR). We analysed the files of 89 patients between August 2010-August 2012 who underwent elective EVAR retrospectively. We performed RA for 32 patients (36%) and GA for 57 patients (64%). The operations were completed successfully in both groups and did not require conventional surgery. The mean age of the patients was 71.5±7 (range 50-88 years). RA was preferred more than GA in the presence of advanced-stage chronic obstructive pulmonary disease statistically (p=0.032). The usage of vasodilator drug and atropine was found to be higher in the GA group than the RA group in the intraoperative period (p=0.001 and p=0.01, respectively). The intensive care unit (ICU) was necessary for 5 patients in the RA group (16%) and 13 patients for the GA group (23%) postoperatively (p=0.301). The median ICU stay in the RA group was 2 hours and 4.4 hours in the GA group (p=0.114). The median hospital stay was 2.63±1.91 days in the RA group and 2.04±1.16 days in the GA group, with no statistically significant difference between groups (p=0.120). There was no mortality of patients in either group for the peroperative period and the 30-day follow-up period. Our present study suggests that patient characteristics are more important than the anaesthetic method on the outcomes of EVAR.

1 February 2017
Verified
Journal Article
Closed access
ECEbru Canakci
Ebru Canakci
ÖYözgür yağan
özgür yağan
NTNilay Tas
Nilay Tas
TMTugce Mutlu
Tugce Mutlu
ACAbdullah Cirakoglu
Abdullah Cirakoglu
EBErdal Benli
Erdal Benli